What is the equity of Hyphens Pharma International this year?
Hyphens Pharma International has equity of 62.99 M SGD this year.
In 2024, Hyphens Pharma International's equity was 62.99 M SGD, a -8.75% increase from the 69.03 M SGD equity in the previous year.
Hyphens Pharma International's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Hyphens Pharma International's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating Hyphens Pharma International's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Hyphens Pharma International's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in Hyphens Pharma International’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Hyphens Pharma International has equity of 62.99 M SGD this year.
The equity of Hyphens Pharma International has increased/decreased by -8.75% decreased compared to the previous year.
A high equity is advantageous for investors of Hyphens Pharma International as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of Hyphens Pharma International, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of Hyphens Pharma International can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of Hyphens Pharma International can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of Hyphens Pharma International include profits, dividend payments, capital increases, and acquisitions.
The equity of Hyphens Pharma International is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, Hyphens Pharma International can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, Hyphens Pharma International paid a dividend of 0.05 SGD . This corresponds to a dividend yield of about 16.24 %. For the coming 12 months, Hyphens Pharma International is expected to pay a dividend of 0.05 SGD.
The current dividend yield of Hyphens Pharma International is 16.24 %.
Hyphens Pharma International pays a quarterly dividend. This is distributed in the months of June, June, September, June.
Hyphens Pharma International paid dividends every year for the past 8 years.
For the upcoming 12 months, dividends amounting to 0.05 SGD are expected. This corresponds to a dividend yield of 18.24 %.
Hyphens Pharma International is assigned to the 'Health' sector.
To receive the latest dividend of Hyphens Pharma International from 5/24/2024 amounting to 0.009 SGD, you needed to have the stock in your portfolio before the ex-date on 5/8/2024.
The last dividend was paid out on 5/24/2024.
In the year 2023, Hyphens Pharma International distributed 0.007 SGD as dividends.
The dividends of Hyphens Pharma International are distributed in SGD.
Our stock analysis for Hyphens Pharma International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hyphens Pharma International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.